LONDON: British drugmaker AstraZeneca on Monday rejected a final $117-billion takeover bid from US rival Pfizer, appearing to put an end to the saga.
Pfizer had lodged a fourth and final offer worth 85 billion euros or £69 billion on Sunday, pitched at £55 per share, adding it would not proceed without a recommendation from management.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.